Chemours Co Stock Alpha and Beta Analysis
| CC Stock | USD 14.40 0.70 5.11% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Chemours Co. It also helps investors analyze the systematic and unsystematic risks associated with investing in Chemours over a specified time horizon. Remember, high Chemours' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Chemours' market risk premium analysis include:
Beta 1.53 | Alpha (0.34) | Risk 3.06 | Sharpe Ratio (0.12) | Expected Return (0.36) |
Chemours Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Chemours |
Chemours Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Chemours market risk premium is the additional return an investor will receive from holding Chemours long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Chemours. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Chemours' performance over market.| α | -0.34 | β | 1.53 |
Chemours expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Chemours' Buy-and-hold return. Our buy-and-hold chart shows how Chemours performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Chemours Market Price Analysis
Market price analysis indicators help investors to evaluate how Chemours stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Chemours shares will generate the highest return on investment. By understating and applying Chemours stock market price indicators, traders can identify Chemours position entry and exit signals to maximize returns.
Chemours Return and Market Media
The median price of Chemours for the period between Mon, Dec 16, 2024 and Sun, Mar 16, 2025 is 17.43 with a coefficient of variation of 11.07. The daily time series for the period is distributed with a sample standard deviation of 1.91, arithmetic mean of 17.24, and mean deviation of 1.49. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
| Chemours dividend paid on 16th of December 2024 | 12/16/2024 |
1 | Insider Trading | 01/03/2025 |
2 | Polytetrafluoroethylene Market Set to Reach 4.3 Billion by 2034, TMR Forecasts 5.8 percent CAGR, Driven by Expanding Applications Across Key Sectors TMR | 01/28/2025 |
3 | Stepan Co. Earnings Expected to Grow What to Know Ahead of Next Weeks Release | 02/12/2025 |
4 | Chemours Launches Ti-Pure TS-6706, A TMPTME- Free Version of Flagship Universal Grade, Ti-Pure R-706 | 02/19/2025 |
5 | Chemours Full Year 2024 Earnings EPS Misses Expectations | 02/21/2025 |
6 | Embracing Nature Chemours Work To Enhance Nature in Its Communities | 02/27/2025 |
7 | Disposition of 1302 shares by Joseph Martinko of Chemours at 14.95 subject to Rule 16b-3 | 02/28/2025 |
8 | Disposition of 1311 shares by Familiar Calderon Gerardo of Chemours at 14.95 subject to Rule 16b-3 | 03/04/2025 |
9 | Polychlorotrifluoroethylene Market Growth Analysis 2025-2030, Featuring Profiles of Key Players - Daikin Industries, Honeywell International, Arkema, Halopolyme... | 03/07/2025 |
10 | The Chemours Company Among the Best Mid-Cap Value Stocks to Buy According to Analysts | 03/10/2025 |
11 | Chemours Joins University of Kansas-Led Collaborative the Environmentally Applied Refrigerant Technology Hub To Advance Sustainable Cooling Technologies | 03/11/2025 |
12 | Refrigerants Market Global Forecast Report 2025-2029, with Key Player Profiles for Arkema, Dongyue, Honeywell, Linde, Sinochem, Daikin Industries, Orbia Advance... | 03/13/2025 |
About Chemours Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Chemours or other stocks. Alpha measures the amount that position in Chemours has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0324 | 0.0317 | 0.0586 | Price To Sales Ratio | 0.7 | 0.78 | 0.44 |
Chemours Upcoming Company Events
As portrayed in its financial statements, the presentation of Chemours' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chemours' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Chemours' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Chemours. Please utilize our Beneish M Score to check the likelihood of Chemours' management manipulating its earnings.
| 14th of February 2024 Upcoming Quarterly Report | View | |
| 25th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Chemours
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Chemours Backtesting, Chemours Valuation, Chemours Correlation, Chemours Hype Analysis, Chemours Volatility, Chemours History and analyze Chemours Performance. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Chemours technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.